GOS1&2 AlimH Webinar – Friday, September 11, 2026, at 1:30 p.m.

Different Perspectives Webinar - GLP-1 : beyond weight loss different perpectives on Physiology, Clinical Practice, and Personalized Medecine

11 September 2026

Webinar

The coordinators of Major Scientific Objectives 1&2 in INRAE’s Human Nutrition Department : Karine Adel-Patient, Sergio Polakof, Stéphanie Chambaron, and Vincent Paillé, are organising a webinar featuring presentations by Chloé Amouyal, an endocrinologist and diabetologist, and Amélie Bonnefond, a research director. A dialogue between medicine and science to better understand the new dimensions of GLP-1 (Glucacon-Like Peptide-1), its agonists, and their metabolic, behavioral, and therapeutic effects.

chloe_amouyal.jpg

Chloé Amouyal, MD, PhD

Endocrinologist and Diabetologist – MCU-PH – Sorbonne University, AP-HP, Paris

GLP-1 receptor agonists: which Treatment for which Patient ?

 

Amelie_Bonnefond.jpeg

Amélie Bonnefond, PhD

Research Director at INSERM – UMR METAB-OMICS, Institut Pasteur de Lille

GLP-1 receptor variants and heterogeneous response to agonists : toward personalized medicine for obesity and diabetes.

 

@Why participate ?

  • Discover two complementary approaches : clinical, mechanistic and translational
  • Explore the links between metabolic regulation, food intake, individual variability, and therapeutic response
  • Discuss the benefits, limitations, and prospects of GLP-1 agonists
  • Talk to two leading experts

 

Contact: vincent.paille@univ-nantes.fr